Industries > Pharma > Stem Cell Technologies and Applications Market Report 2023-2033
Back to Pharma Reports
Stem Cell Technologies and Applications Market Report 2023-2033

Stem Cell Technologies and Applications Market Report 2023-2033

Forecasts by Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), by Cell Source (Adipose Tissue-derived MSCs, Bone Marrow-derived MSCs, Placental/Umbilical Cord-derived MSCs), by Product (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells), by Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion & Sub-culture, Other), by Application (Cancer, Cardiovascular Diseases, Neurological Disorders, Inflammatory & Autoimmune Diseases, Musculoskeletal Disorders, Other), by End-use (Pharmaceutical & Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

PUBLISHED: 06 November 2023
PAGES: 337
PRODUCT CODE: PHA1293
SUBMARKET: Drug Discovery Development & Production Next Generation Technologies Therapeutic Drugs

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1293 Categories: , , , Tags: ,

The Stem Cell Technologies and Applications Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to understand the industry and its underlying dynamics better. It will be useful for companies that want to expand into different industries or their existing operations in a new region.

Growing Government Support Driving Market Growth
Growing government support for stem cell research and development is fuelling the growth of stem cell companies. In 2022, we saw a number of significant developments in this area. Global governments are making significant investments in stem cell research. For instance, the US National Institutes of Health (NIH) funded stem cell research with $3.7 billion in 2022. New programmes are being introduced by governments to assist stem cell companies. In 2022, for instance, the UK government established a new fund worth £30 million ($37 million) to assist stem cell firms in introducing novel therapies to the market.

Furthermore, there is a developing trend in the industry. This indicates that investors’ interest in this industry is rising. Verve Therapeutics, a stem cell firm, raised $100 million at its first public offering (IPO) in 2022.

The following are a few specific advances in stem cell companies that happened in 2022:
• Clinical studies for stem cell therapies: In 2022, several stem cell therapies were introduced into clinical trials. For instance, a Phase 3 clinical trial for the stem cell therapy for sickle cell disease was started by Bluebird Bio.
• Regulatory clearances for stem cell companies: In 2022, a number of stem cell companies were granted regulatory approvals. For instance, Kite Pharma, a stem cell business, was approved by the FDA to use stem cells to treat non-Hodgkin lymphoma.

These are but a handful of the numerous advancements that the stem cell sector saw in 2022. This rise is mostly due to the growing support from the government, which is expected to encourage the creation of new stem cell medicines as well as the expansion of stem cell companies in the years to come.

High Cost of Stem Cell Therapies to Hamper Industry Growth
A variety of illnesses and disorders may be treated or made better with the help of stem cell therapy, a cutting-edge medical innovation. The high expense of stem cell therapy is one of the main obstacles, though. Depending on the type of stem cells utilised, the ailment being treated, and the location of the treatment centre, the average cost of stem cell therapy today ranges from $5,000 to $50,000.

The high price of stem cell therapy is caused by a variety of variables. The price of creating and developing stem cell therapies is one of the factors. The production of stem cell therapies is difficult and demands a high level of knowledge and technology. The expense of stem cell therapies is further increased by the fact that they are frequently customised for each patient.

The absence of insurance coverage is another reason that raises the price of stem cell therapy. Due to the fact that stem cell therapy is currently regarded as an experimental procedure, the majority of insurance companies do not cover it. This implies that patients frequently bear the financial burden of covering the entire expense of treatment.

What Questions Should You Ask Before Buying a Market Research Report?
• How is the stem cell technologies and applications market evolving?
• What is driving and restraining stem cell technologies and applications market?
• How will each stem cell technologies and applications submarket segment grow over the forecast period, and how much revenue will these submarkets account for in 2033?
• How will the market shares for each stem cell technologies and applications submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading stem cell technologies and applications markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033, and which geographical region will lead the market in 2033?
• Who are the leading players, and what are their prospects over the forecast period?
• What are the stem cell technologies and applications projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of stem cell technologies and applications projects taking place now and over the next 10 years?
• Is there a greater need for product commercialization to further scale stem cell technologies and applications market?
• Where is the stem cell technologies and applications market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the stem cell technologies and applications market today, and over the next 10 years:
• Our 337-page report provides 119 tables and 198 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the stem cell technologies and applications market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising stem cell technologies and applications prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Type Outlook
• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy

Cell Source
• Adipose Tissue-derived MSCs
• Bone Marrow-derived MSCs
• Placental/Umbilical Cord-derived MSCs

Product
• Adult Stem Cells
• Human Embryonic Stem Cells
• Induced Pluripotent Stem Cells
• Very Small Embryonic Like Stem Cells

Technology
• Cell Acquisition
• Cell Production
• Cryopreservation
• Expansion & Sub-culture
• Other Technology

Application
• Cancer
• Cardiovascular Diseases
• Neurological Disorders
• Inflammatory & Autoimmune Diseases
• Musculoskeletal Disorders
• Other Applications

End-Use
• Pharmaceutical & Biotechnology Companies
• Hospitals & Cell Banks
• Academic & Research Institutes

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and the U.S., China, U.K., India, and Brazil leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

Stem Cell Technologies and Applications Market Report 2023-2033
Need industry data? Please contact us today.

The report also includes profiles and for some of the leading companies in the Stem Cell Technologies and Applications Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading Companies and the Potential for market growth
• Athersys, Inc.
• Becton, Dickinson and Company
• Biorestorative Therapies, Inc.
• CELLAÏON SA
• Cynata Therapeutics Limited
• Merck KGaA
• Mesoblast Limited
• Plus Therapeutics, Inc.
• Sangamo Therapeutics, Inc.
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.
• Vericel Corporation

Overall world revenue for Stem Cell Technologies and Applications Market, 2023 to 2033 in terms of value the market will surpass US$10,000.0 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Stem Cell Technologies and Applications Market, 2023 to 2033 report help you?
In summary, our 330+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Stem Cell Technologies and Applications Market, 2023 to 2033 Market, with forecasts for type, cell source, product, technology, application, and end use each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 20 key national markets – See forecasts for the Stem Cell Technologies and Applications Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for Thermo Fisher Scientific Inc., Becton, Dickinson and Company, STEMCELL Technologies Inc., Merck KGaA of the major companies involved in the Stem Cell Technologies and Applications Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Stem Cell Technologies and Applications Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Stem Cell Technologies and Applications Market Report 2023-2033: Forecasts by Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), by Cell Source (Adipose Tissue-derived MSCs, Bone Marrow-derived MSCs, Placental/Umbilical Cord-derived MSCs), by Product (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells), by Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion & Sub-culture, Other), by Application (Cancer, Cardiovascular Diseases, Neurological Disorders, Inflammatory & Autoimmune Diseases, Musculoskeletal Disorders, Other), by End-use (Pharmaceutical & Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Stem Cell Technologies and Applications Market Report 2023-2033

    Related reports

    Download sample pages

    Complete the form below to download your free sample pages for Stem Cell Technologies and Applications Market Report 2023-2033

      Connect with us

      Visiongain Pharma

      Visiongain Pharma

      Visiongain Pharma

      Latest Pharma news

      Visiongain Publishes Peripheral Vascular Device Market Report 2024-2034

      The global Peripheral Vascular Devices market is estimated at US$12.49 billion in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period 2024-2034.

      30 April 2024

      READ
      Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

      The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

      23 April 2024

      READ
      Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

      The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

      18 April 2024

      READ
      Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

      The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

      17 April 2024

      READ